In order to ensure complete compliance with both institutional and international standards for animal research, all following operations, such as animal housing and care, dosing regimen, blood collection, and euthanasia, were carried out strictly in line with this authorized protocol
Reviewed by: FormBlends Medical Team | Last updated: May 29, 2026 | Sources: USP general chapters, FDA compounding guidance, peer-reviewed GLP-1/GIP pharmacology literature, manufacturer prescribing information
NNC0165-1273 reduces nocturnal food intake, attenuates feeding behavior, induces early satiety, and causes dose-dependent decreases in body weight and fat mass in diet-induced obese mice
In the following days, daily maintenance doses are usually in the range of 50 mg/kg
14/10/2025 absorbed quickly nongreasy 5/7/2026 Gud Nice product 14/4/2026 Too good The product is too Everyone can use this product 28/3/2026 Best and value for money 1/3/2026 Very nice So good 4/10/2025 very good for dry skin in winter season 4/10/2025 money worthy good for dry skin
Key GLP-1 Receptor Agonist Cardiovascular Outcome Trials Why Do GLP-1 Medications Protect the Heart